Indication
Systemic Allergic Reaction
1 clinical trial
2 products
Clinical trial
A Randomized, Placebo-controlled Crossover Study to Assess the Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial DoseStatus: Completed, Estimated PCD: 2022-06-17
Product
Comirnaty